Bluejay Diagnostics (BJDX) Enterprise Value (2020 - 2026)

Bluejay Diagnostics' Enterprise Value history spans 3 years, with the latest figure at -$2.2 million for Q4 2023.

  • On a quarterly basis, Enterprise Value rose 78.17% to -$2.2 million in Q4 2023 year-over-year; TTM through Dec 2023 was -$2.2 million, a 78.17% increase, with the full-year FY2023 number at -$2.2 million, up 78.17% from a year prior.
  • Enterprise Value hit -$2.2 million in Q4 2023 for Bluejay Diagnostics, up from -$5.1 million in the prior quarter.
  • Over the last five years, Enterprise Value for BJDX hit a ceiling of -$2.2 million in Q4 2023 and a floor of -$19.0 million in Q4 2021.
  • Historically, Enterprise Value has averaged -$10.5 million across 3 years, with a median of -$10.1 million in 2022.
  • Biggest five-year swings in Enterprise Value: soared 46.9% in 2022 and later skyrocketed 78.17% in 2023.
  • Tracing BJDX's Enterprise Value over 3 years: stood at -$19.0 million in 2021, then soared by 46.9% to -$10.1 million in 2022, then skyrocketed by 78.17% to -$2.2 million in 2023.
  • Business Quant data shows Enterprise Value for BJDX at -$2.2 million in Q4 2023, -$5.1 million in Q3 2023, and -$5.1 million in Q2 2023.